ATE121779T1 - Nichtzurückschlagende rns-viren. - Google Patents

Nichtzurückschlagende rns-viren.

Info

Publication number
ATE121779T1
ATE121779T1 AT88121231T AT88121231T ATE121779T1 AT E121779 T1 ATE121779 T1 AT E121779T1 AT 88121231 T AT88121231 T AT 88121231T AT 88121231 T AT88121231 T AT 88121231T AT E121779 T1 ATE121779 T1 AT E121779T1
Authority
AT
Austria
Prior art keywords
rns
viruses
repeat
vaccines
relates
Prior art date
Application number
AT88121231T
Other languages
English (en)
Inventor
Carolyn Louise Weeks-Levy
Steven Joseph Mento
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE121779T1 publication Critical patent/ATE121779T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
AT88121231T 1988-01-11 1988-12-19 Nichtzurückschlagende rns-viren. ATE121779T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14250788A 1988-01-11 1988-01-11

Publications (1)

Publication Number Publication Date
ATE121779T1 true ATE121779T1 (de) 1995-05-15

Family

ID=22500099

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88121231T ATE121779T1 (de) 1988-01-11 1988-12-19 Nichtzurückschlagende rns-viren.

Country Status (9)

Country Link
EP (1) EP0325768B1 (de)
JP (1) JPH01222774A (de)
AT (1) ATE121779T1 (de)
AU (1) AU2833789A (de)
DE (1) DE3853672T2 (de)
DK (1) DK8789A (de)
ES (1) ES2070846T3 (de)
FI (1) FI890116A7 (de)
IL (1) IL88731A0 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286640A (en) * 1988-01-05 1994-02-15 Almond Jeffrey W Attenuated polioviruses
US5298416A (en) * 1989-01-18 1994-03-29 British Technology Group Ltd. Attenuated polioviruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
EP0401421B1 (de) * 1989-06-08 1996-01-03 American Cyanamid Company Nicht-zurückmutierende RNA-Viren
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
US6853093B2 (en) 2002-12-20 2005-02-08 Lipman Electronic Engineering Ltd. Anti-tampering enclosure for electronic circuitry
US8405506B2 (en) 2010-08-02 2013-03-26 Verifone, Inc. Secure data entry device
US8593824B2 (en) 2010-10-27 2013-11-26 Verifone, Inc. Tamper secure circuitry especially for point of sale terminal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
JPS59173084A (ja) * 1982-11-30 1984-09-29 インステイチユ−ト・パスツ−ル ポリオウイルスの免疫原性部位よりなるペプチド類及びこれらのペプチド類を暗合化するヌクレオチド配列を含有するdna類
EP0156299A3 (de) * 1984-03-26 1987-04-01 Chiron Corporation LTR-modifizierte virale Vakzine

Also Published As

Publication number Publication date
DK8789A (da) 1989-07-12
FI890116L (fi) 1989-07-12
DE3853672T2 (de) 1996-01-11
DE3853672D1 (de) 1995-06-01
EP0325768B1 (de) 1995-04-26
EP0325768A3 (en) 1989-08-30
EP0325768A2 (de) 1989-08-02
ES2070846T3 (es) 1995-06-16
AU2833789A (en) 1989-07-13
FI890116A0 (fi) 1989-01-10
FI890116A7 (fi) 1989-07-12
DK8789D0 (da) 1989-01-10
IL88731A0 (en) 1989-07-31
JPH01222774A (ja) 1989-09-06

Similar Documents

Publication Publication Date Title
DE10399031I1 (de) Rekombinante Viren.
DE68929467D1 (de) HIV-2 Varianten
GR3034708T3 (en) Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.
ATE129160T1 (de) Herpes-simplex-impfstoff, der hsv-glycoprotein-gd und 3-deacyl monophosphoryl-lipid-a enthaelt.
FI882263A7 (fi) Vanadiinitetrakloridin stabilointi.
ES2042751T3 (es) Nuevo procedimiento para la purificacion de viriones de la hepatitis a.
DK0386734T3 (da) Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
DE3885431D1 (de) Expression der viral kodierten Protease P2A des HRV2.
PT84155A (en) Method of modifying plant viruses or their effects
DK0404625T3 (da) Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus
FI890116A0 (fi) Icke-reverterande rna-virus.
ES292573Y (es) Autoclave de esterilizacion por medio de un gas o de una mezcla de gas-vapor.
NO880935D0 (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
DE3685413D1 (de) Insektizide und viren.
FI872154A7 (fi) Viruksen inaktivointi.
AU630099B2 (en) Non-reverting rna viruses
FI881123L (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
FI841094A7 (fi) Kantajaan sidottu virusantigeeni, sen valmistus ja käyttö.
NO891355D0 (no) Vaksinasjon mot rabis-beslektede virus.
IT8520740A0 (it) Procedimento per la concentrazione di virus da fluidi.
ATE96839T1 (de) Expression der viral kodierten protease p2a des hrv2.
FI880628A7 (fi) Nukleotidianalogit, niiden valmistus ja käyttö.
TR27738A (tr) Paslanmaz celigin termik islemi.
IT8321041A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee